The "Growtropin" Company

Dong-A has been the largest pharmaceutical company in Korea since 1967. We have solidified our leading market position on the strength of in-house developed products such as Growtropin. Evogliptin, the DPP-4 inhibitor for type 2 diabetes mellitus, Zydena tab. Udenafil, the fourth PDE5 inhibitor in the world for erectile dysfunction, Stillen tab. Eupatilin for herbal treatment of gastritis and Motilitone tab. Corydaline for functional dyspepsia. Furthermore, we are offering branded generic drugs (anti-cancer, anti-TB, etc.), bio-pharmaceutical, IMD, APIs and OTC products ensuring full compliance to international quality standard. Currently Dong-A is exporting its products to more than 50 countries to leading pharmaceutical companies in Europe, Latin America and Asia.